CINECA IRIS Institutional Research Information System

ROCCATELLO, Dario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 50.185
EU - Europa 36.836
AS - Asia 31.657
SA - Sud America 7.461
Continente sconosciuto - Info sul continente non disponibili 3.143
AF - Africa 1.022
OC - Oceania 687
Totale 130.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.950
IT - Italia 12.330
CN - Cina 10.568
SG - Singapore 7.789
FR - Francia 3.746
BR - Brasile 3.675
JP - Giappone 3.277
DE - Germania 2.946
ES - Italia 2.919
VN - Vietnam 2.224
GB - Regno Unito 2.172
MX - Messico 2.087
IE - Irlanda 2.085
FI - Finlandia 1.766
SE - Svezia 1.654
CA - Canada 1.512
KR - Corea 1.446
IN - India 1.318
UA - Ucraina 1.293
CO - Colombia 1.169
AR - Argentina 1.111
PL - Polonia 854
HK - Hong Kong 825
NL - Olanda 797
TR - Turchia 769
AU - Australia 628
RU - Federazione Russa 599
CL - Cile 504
CH - Svizzera 484
TW - Taiwan 484
GR - Grecia 468
ID - Indonesia 467
AT - Austria 396
BE - Belgio 390
PT - Portogallo 386
TH - Thailandia 380
BD - Bangladesh 355
PE - Perù 333
RO - Romania 318
IL - Israele 296
EC - Ecuador 281
SA - Arabia Saudita 206
DK - Danimarca 192
IQ - Iraq 186
EG - Egitto 182
VE - Venezuela 172
MA - Marocco 160
TN - Tunisia 142
CZ - Repubblica Ceca 136
HU - Ungheria 135
PK - Pakistan 132
PH - Filippine 128
JM - Giamaica 127
ZA - Sudafrica 127
NO - Norvegia 121
IR - Iran 117
RS - Serbia 114
MY - Malesia 109
CR - Costa Rica 107
SI - Slovenia 103
DZ - Algeria 102
HR - Croazia 93
UY - Uruguay 90
PY - Paraguay 64
UZ - Uzbekistan 62
BG - Bulgaria 60
AE - Emirati Arabi Uniti 59
GT - Guatemala 56
EU - Europa 55
NZ - Nuova Zelanda 55
BO - Bolivia 53
NP - Nepal 49
KE - Kenya 47
DO - Repubblica Dominicana 46
PS - Palestinian Territory 46
NI - Nicaragua 45
TT - Trinidad e Tobago 44
HN - Honduras 43
JO - Giordania 42
RE - Reunion 42
OM - Oman 40
PA - Panama 37
SK - Slovacchia (Repubblica Slovacca) 34
SV - El Salvador 33
CY - Cipro 31
LT - Lituania 31
BY - Bielorussia 30
LB - Libano 30
EE - Estonia 29
KZ - Kazakistan 29
LV - Lettonia 29
MU - Mauritius 29
NG - Nigeria 28
KW - Kuwait 25
MT - Malta 25
QA - Qatar 25
AL - Albania 24
AZ - Azerbaigian 24
PR - Porto Rico 24
SN - Senegal 24
Totale 127.481
Salva come PNG Salva come JPEG
Città #
Singapore 4.230
Beijing 3.531
Ashburn 2.837
Santa Clara 2.411
Chandler 2.055
San Jose 2.045
Dublin 1.998
Redwood City 1.898
Milan 1.658
Houston 1.589
Fairfield 1.546
Ann Arbor 1.342
Wilmington 939
Tokyo 926
Rome 914
Torino 914
Jacksonville 908
Turin 830
Helsinki 828
Villeurbanne 826
Woodbridge 813
Council Bluffs 760
Seattle 692
Shanghai 682
Medford 668
Dearborn 659
Los Angeles 655
Princeton 612
Columbus 605
Ho Chi Minh City 579
New York 560
São Paulo 553
Hong Kong 550
Lauterbourg 547
The Dalles 546
Cambridge 539
Warsaw 516
Guangzhou 500
Seoul 494
Hanoi 489
Madrid 468
Bogotá 444
Dallas 417
Hefei 415
Pisa 403
Paris 394
Buffalo 390
Barcelona 374
Santiago 367
Munich 360
Nyköping 353
Buenos Aires 321
Boston 306
Chicago 306
Nanjing 298
Hangzhou 293
Medellín 280
Dong Ket 277
Mexico City 272
Jakarta 262
London 247
Bologna 243
Toronto 238
Florence 237
Lima 236
Atlanta 232
Chengdu 217
Taipei 217
Vienna 216
Verona 206
Naples 204
Boardman 195
Fremont 192
Istanbul 187
Bangkok 181
Mexico 181
Wuhan 181
Frankfurt am Main 179
Athens 174
Bengaluru 172
Osaka 171
Zhengzhou 171
Washington 158
Rio de Janeiro 153
Sesto San Giovanni 153
San Diego 145
Guadalajara 144
Sydney 142
Phoenix 141
Philadelphia 138
Changsha 136
Jinan 133
Amsterdam 127
Rochester 127
Palermo 124
Quito 123
Valencia 123
Berlin 117
Ankara 116
Ottawa 116
Totale 60.137
Salva come PNG Salva come JPEG
Nome #
Cryoglobulinaemia 8.006
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances 4.126
GAPSS: the Global Anti-Phospholipid Syndrome Score. 2.587
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2.255
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. 1.730
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature 1.723
Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review 1.472
Renal involvement in antiphospholipid syndrome. 1.395
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 1.349
Acute renal infarction: a single center experience 1.270
IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine. 1.230
Acute kidney injury associated with glomerular diseases 1.204
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.196
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. 1.115
Radiotherapy in patients with connective tissue diseases 1.037
IgG4-related nephropathy 1.033
Antiphospholipid Syndrome and the Kidney 1.021
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. 914
Dealing with stuck hemodialysis catheter: state of the art and tips for the nephrologist. 871
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment 869
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein) 867
[Extracorporeal therapy in sepsis] 828
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome 747
The global anti-phospholipid syndrome score in primary APS. 732
Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence 720
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 701
Pregnancy outcomes in mixed connective tissue disease: a multicentre study 696
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. 684
Catastrophic antiphospholipid syndrome (CAPS). 672
Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review 671
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 655
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 646
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 631
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 629
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 621
Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials 612
Rheumatoid arthritis: Biological therapy other than anti-TNF 592
Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review 572
Living With and Treating Rare Diseases: Experiences of Patients and Professional Health Care Providers 565
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: A pooled analysis 561
Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. 559
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 549
Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome 545
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 524
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 519
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 517
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 516
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 501
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 487
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 479
Anticorpi anti-GM1 ed anti-solfatidi nelle vasculiti sistemiche primitive e secondarie 477
Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. 453
Nemo syndrome (incontinentia pigmenti) and systemic lupus erythematosus: a new disease association. 450
Treatment of antiphospholipid syndrome 437
Radiotherapy in patients with HIV: current issues and review of the literature 431
Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target? 427
The risk of ischaemic stroke in primary APS patients: a prospective study 421
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 418
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 411
Venous Window Needle Guide for deep vessels and difficult arteriovenous fistula cannulation 404
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 403
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies 387
A randomized, controlled, trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 382
[A new test (conglutinin solid phase with anti IgA) for the detection of serum immune complexes in IgA antibody components] 375
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study) 367
The dilemma of treating hepatitis C virus-associated cryoglobulinemia 361
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 360
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 358
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning. 357
Upcoming biological therapies in systemic lupus erythematosus. 356
Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. 352
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome 342
Fagocitosi monocitaria frusta di crioglobuline in pazienti con nefrite crioglobulinemica 331
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome 328
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets 325
DNAJB9 Is a Reliable Immunohistochemical Marker of Fibrillary Glomerulonephritis: Evaluation of Diagnostic Efficacy in a Large Series of Kidney Biopsies 324
"How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis 324
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 322
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 318
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 314
Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome. 299
How I treat patients with systemic sclerosis in clinical practice 297
Rituximab in cryoglobulinemic peripheral neuropathy 288
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 280
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis 278
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 274
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 271
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 270
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 268
The Case | the young philosopher with multiple sclerosis and proteinuria 268
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 264
Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort. 262
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 256
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 256
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score 253
Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome. 251
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 250
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 246
Novel diagnostic approaches and cost-benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: lessons from the 15th Turin Congress on Immune Pathology and Orphan Disease. 245
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS 244
Totale 71.636
Salva come PNG Salva come JPEG
Categoria #
all - tutte 315.600
article - articoli 0
book - libri 0
conference - conferenze 41.690
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 357.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.492 0 0 0 932 938 819 823 817 782 672 1.134 1.575
2022/202312.031 1.083 763 521 840 975 2.344 1.189 992 1.152 599 818 755
2023/20249.351 993 1.028 726 777 851 679 704 770 207 686 803 1.127
2024/202516.404 606 972 879 1.536 3.077 1.187 808 1.136 1.686 1.204 1.169 2.144
2025/202628.789 1.848 1.530 1.706 3.223 2.363 1.750 3.384 1.589 2.402 1.925 2.274 4.795
2026/20277.773 1.506 2.844 2.198 1.225 0 0 0 0 0 0 0 0
Totale 130.991